Changes of adiponectin and its receptors in rats following chronic renal failure

References

• Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002;8:1288–1295
   PubMed Web of Science ®Google Scholar
• Santaniemi M, Kesaniem YA, Ukkola O. Low plasma adiponectin concentration is an indicator of the metabolic syndrome. Eur J Endocrinol. 2006;155:745–750
   PubMed Web of Science ®Google Scholar
• Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med. 2001;7:947–953
   PubMed Web of Science ®Google Scholar
• Kamimura MA, Canziani ME, Sanches FR, et al. Variations in adiponectin levels in patients with chronic kidney disease: a prospective study of 12 months. J Bras Nefrol. 2012;34(3):259–265
   Google Scholar
• Guebre-Egziabher F, Bernhard J, Funahashi T, Hadj-Aissa A, Fouque D. Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function. Nephrol Dial Transplant. 2005;20:129–134
   PubMed Web of Science ®Google Scholar
• Cui J, Panse S, Falkner B. The role of adiponectin in metabolic and vascular disease: a review. Clin Nephrol. 2011;75:26–33
   Google Scholar
• Shibata R, Ouchi N, Murohara T. Adiponectin and cardiovascular disease. Circ J. 2009;73:608–614
   PubMed Web of Science ®Google Scholar
• Adamczak M, Chudek J, Wiecek A. Adiponectin in patients with chronic kidney disease. Semin Dial. 2009;22:391–395
   PubMedGoogle Scholar
• Zoccali C, Mallamaci F. Obesity, diabetes, adiponectin and the kidney: a podocyte affair. Nephrol Dial Transplant. 2008;23:3767–3770
   Google Scholar
• Nakagawa N, Yao N, Hirayama T, et al. Potential impact of renin--angiotensin system inhibitors and calcium channel blockers on plasma high-molecular-weight adiponectin levels in hemodialysis patients. Hypertens Res. 2011;34:592–598
   Google Scholar
• Yokozawa T, Zheng PD, Oura H, Koizumi F. Animal model of adenine-induced chronic renal failure in rats. Nephron. 1986;44:230–234
   PubMed Web of Science ®Google Scholar
• Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 1995;270:26746–26749
   PubMed Web of Science ®Google Scholar
• Fan YP, Yu Y. Intervention of dyslipidemia in chronic kidney disease. Chinese J Nephrol. 2010;26:233–237
   Google Scholar
• Cammisotto PG, Bendayan M. Adiponectin stimulates phosphorylation of AMP-activated protein kinase alpha in renal glomeruli. J Mol Histol. 2008;39:579–584
   PubMed Web of Science ®Google Scholar
• Zhou Z, Wu XY, Yao T, Gao P, Yu WL, Yang GM. Protective effect of adiponectin and its receptors in diabetic nephropathy rats. Chinese J Nephrol. 2010;26:702–707
   Google Scholar
• Fujita H, Morii T, Koshimura J, et al. Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy. Endocr J. 2006;53:745–752
   PubMedGoogle Scholar
• Shen YY, Hughes JT, Charlesworth JA, Kelly JJ, Peake PW. Adiponectin is present in the urine in its native conformation and specifically reduces the secretion of MCP-1 by proximal tubular cells. Nephrology (Carlton). 2008;13:405–410
   PubMed Web of Science ®Google Scholar
• Yaturu S, Reddy RD, Rains J, Jain SK. Plasma and urine levels of resistin and adiponectin in chronic kidney disease. Cytokine. 2007;37:1–5
   PubMedGoogle Scholar
• Malyszko J, Malyszko JS, Brzosko S, Wolczynski S, Mysliwiec M. Adiponectin is related to CD146, a novel marker of endothelial cell activation/injury in chronic renal failure and peritoneally dialyzed patients. J Clin Endocrinol Metab. 2004;89:4620–4627
   PubMedGoogle Scholar
• Stenvinkel P. Adiponectin in chronic kidney disease: a complex and context sensitive clinical situation. J Ren Nutr. 2011;21:82–86
   Google Scholar
• Devarajan P. The use of targeted biomarkers for chronic kidney disease. Adv Chr Kid Dis. 2010;17:469–479
   PubMed Web of Science ®Google Scholar
• Risch L, Saely C, Hoefle G, et al. Relationship between glomerular filtration rate and the adipokines adiponectin, resistin and leptin in coronary patients with predominantly normal or mildly impaired renal function. Clin Chim Act. 2007;376:108–113
   PubMed Web of Science ®Google Scholar
• Kawamoto R, Tabara Y, Kohara K, et al. Serum high molecular weight adiponectin is associated with mild renal dysfunction in Japanese adults. J Athero Thromb. 2010;17:1141–1148
   Google Scholar
• Becker B, Kronenberg F, Kielstein JT, et al. Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol. 2005;16:1091–1098
   PubMed Web of Science ®Google Scholar
• Lin J, Hu FB, Curhan G. Serum adiponectin and renal dysfunction in men with type 2 diabetes. Diabet Care. 2007;30:239–244
   PubMedGoogle Scholar